Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.

Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG.

Urology. 2008 Aug;72(2):422-7. doi: 10.1016/j.urology.2008.03.032. Epub 2008 Jun 17.

2.

Quality of life and satisfaction with outcome among prostate-cancer survivors.

Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT.

N Engl J Med. 2008 Mar 20;358(12):1250-61. doi: 10.1056/NEJMoa074311.

3.

Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.

Smith MR, Lee H, McGovern F, Fallon MA, Goode M, Zietman AL, Finkelstein JS.

Cancer. 2008 May 15;112(10):2188-94. doi: 10.1002/cncr.23440.

4.

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M.

JAMA. 2008 Feb 27;299(8):914-24. doi: 10.1001/jama.299.8.914. Review.

PMID:
18314434
5.

Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer--a prospective multicenter study with long-term follow-up.

Frisk J, Spetz AC, Hjertberg H, Petersson B, Hammar M.

Eur Urol. 2009 Jan;55(1):156-63. doi: 10.1016/j.eururo.2008.02.002. Epub 2008 Feb 14.

PMID:
18294761
6.

Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.

Basso U, Tonti S, Bassi C, Brunello A, Pasetto LM, Scaglione D, Falci C, Beda M, Aversa SM, Stefani M, Castegnaro E, Tamellini F, Monfardini S.

Crit Rev Oncol Hematol. 2008 May;66(2):163-70. doi: 10.1016/j.critrevonc.2007.12.006. Epub 2008 Feb 19.

PMID:
18243726
7.

Role of erythropoietin in cancer-related anaemia: a double-edged sword?

Guan X, Chen L.

J Int Med Res. 2008 Jan-Feb;36(1):1-8. Review.

PMID:
18230261
8.

Tai Chi Chuan exercises in enhancing bone mineral density in active seniors.

Lui PP, Qin L, Chan KM.

Clin Sports Med. 2008 Jan;27(1):75-86, viii. doi: 10.1016/j.csm.2007.09.002. Review.

PMID:
18206569
9.

Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?

Higano CS.

Nat Clin Pract Urol. 2008 Jan;5(1):24-34. doi: 10.1038/ncpuro0995. Review.

PMID:
18185511
10.
11.

Interventions for sexual dysfunction following treatments for cancer.

Miles CL, Candy B, Jones L, Williams R, Tookman A, King M.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005540. Review. Update in: Cochrane Database Syst Rev. 2016;2:CD005540.

PMID:
17943864
12.

Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.

Teloken PE, Ohebshalom M, Mohideen N, Mulhall JP.

J Urol. 2007 Dec;178(6):2521-5. Epub 2007 Oct 15.

PMID:
17937948
13.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
14.

Pilot evaluation of flaxseed for the management of hot flashes.

Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL.

J Soc Integr Oncol. 2007 Summer;5(3):106-12.

PMID:
17761129
15.

Physical function in men with prostate cancer on androgen deprivation therapy.

Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL.

Phys Ther. 2007 Oct;87(10):1325-33. Epub 2007 Aug 7.

PMID:
17684084
16.

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.

Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS; Urologic Diseases in America Project.

Cancer. 2007 Oct 1;110(7):1493-500.

17.

Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy.

Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, McWhorter LT.

Urology. 2007 Jul;70(1):122-6.

PMID:
17656221
18.

Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy.

Yee EF, White RE, Murata GH, Handanos C, Hoffman RM.

J Gen Intern Med. 2007 Sep;22(9):1305-10. Epub 2007 Jul 17.

19.
20.

A practical approach to geriatric assessment in oncology.

Rodin MB, Mohile SG.

J Clin Oncol. 2007 May 10;25(14):1936-44. Review.

PMID:
17488994

Supplemental Content

Support Center